Article
Rapid melting curve analysis for genetic variants that underlie inter-individual variability in stable warfarin dosing.
Journal of thrombosis and thrombolysis - 1 Aug 2008
Carlquist John F, McKinney Jason T, Nicholas Zachary P, Clark Jessica L, Kahn Samera F, Horne Benjamin D, Muhlestein Joseph B, May Heidi T, Anderson Jeffrey L
Abstract excerpt
Warfarin anticoagulation therapy is complicated by its narrow therapeutic index and by wide inter-individual differences in dosing requirements arising, in part, from genetic factors. The present report describes the development, validation and feasibility testing of a rapid genotyping assay that concurrently detects the CYP2C9*2 and *3 variants along with the VKORC1 C1173T polymorphism. The study employed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
